Two cohorts (GSE3141 and GSE4573) of lung cancer demonstrated that high expression level of LPAR6 was associated with better prognosis (OS HR = 0.53, 95% CI = 0.36 to 0.80, Cox p = 0.00206181; OS HR = 0.53, 95% CI = 0.31 to 0.91, Cox p = 0.0219869). Here, LPAR6 is linked to lung carcinoma.